Actively Recruiting
Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation
Led by University of Alberta · Updated on 2025-11-17
300
Participants Needed
15
Research Sites
519 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
INTERLIVER is a prospective observational study of the relationship of the molecular phenotype of 300 liver transplant biopsies to the histologic phenotype and the clinical features and outcomes. A segment of a biopsy performed as standard-of-care for indications, or by center protocol, will be used for gene expression study.
CONDITIONS
Official Title
Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Biopsy performed for clinical indications
You will not qualify if you...
- No consent to participate
- Pregnant women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 15 locations
1
University of California San Francisco, Transplant Research Unit
San Francisco, California, United States, 94143
Completed
2
Northwestern Memorial Hospital
Chicago, Illinois, United States, 60611
Completed
3
University of Maryland School of Medicine
Baltimore, Maryland, United States, 21201
Completed
4
Henry Ford Transplant Institute
Detroit, Michigan, United States, 48202
Actively Recruiting
5
Vanderbilt University Medical Center, Vanderbilt Transplant Center
Nashville, Tennessee, United States, 37232
Withdrawn
6
Baylor University Medical Center, Annette C. and Harold C. Simmons Transplant Institute
Dallas, Texas, United States, 75246
Completed
7
Transplant Surgery, VCU Medical Center
Richmond, Virginia, United States, 23298
Completed
8
Division of Transplant Surgery, University of Washington
Seattle, Washington, United States, 98195
Completed
9
Centenary Institute of Cancer Medicine & Cell Biology, Royal Prince Alfred Hospital
Camperdown, Australia, NSW 2050
Completed
10
University of Alberta, Laboratory Medicine and Pathology
Edmonton, Alberta, Canada, T6G 2R7
Completed
11
Dep. of Nephrology, Transplantation & Internal Med., Samodzielny Publiczny Szpital Kliniczny im. A. Mieleckiego
Katowice, Poland, 40-027
Completed
12
Independent Public Composite Regional Hospital
Szczecin, Poland, 71-455
Completed
13
Warsaw Medical University, Jesus the Child Clinical Hospital
Warsaw, Poland, 02-005
Completed
14
Warsaw Medical University, Independent Public Clinical Hospital
Warsaw, Poland, 02-097
Completed
15
Institute for Liver Science, King's College London
London, United Kingdom, SE5 9NU
Completed
Research Team
K
Konrad S Famulski, PhD
CONTACT
R
Robert Polakowski, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here